Related references
Note: Only part of the references are listed.Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis
X. Qi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis Similarities and Differences
Jasper H. Smalberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
J. Hoekstra et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis
Niamh McCarthy et al.
ACTA HAEMATOLOGICA (2010)
The epidemiology and clinical features of portal vein thrombosis: a multicentre study
R. Rajani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis
D. W. Orr et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
JAK2 Mutations Across a Spectrum of Venous Thrombosis Cases
Shrimati Shetty et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt
Alexandra Zahn et al.
BMC GASTROENTEROLOGY (2010)
JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis
Sandra Guerra Xavier et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-up Study
Aurelie Plessier et al.
HEPATOLOGY (2010)
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms
Alessia Fiorini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Sarwa Darwish Murad et al.
ANNALS OF INTERNAL MEDICINE (2009)
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
Francesco Dentali et al.
BLOOD (2009)
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
Selcuk Sozer et al.
BLOOD (2009)
Vascular Disorders of the Liver
Laurie D. DeLeve et al.
HEPATOLOGY (2009)
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience
Rupesh Rajani et al.
LIVER INTERNATIONAL (2009)
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics
Ayalew Tefferi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction
Gaetano M. Bergamaschi et al.
BLOOD (2008)
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome
Donatella Colaizzo et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: The utility of the JAK2 617F mutation
Stephanie P'ng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
JAK2V617F mutation in patients with portal vein thrombosis
Yusuf Bayraktar et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis
C. Goulding et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2008)
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation
R. Landolfi et al.
LEUKEMIA (2008)
Etiology and portal vein thrombosis in Budd-Chiari syndrome
Oguz Uskudar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
Linda M. Scott et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses
Lucio Amitrano et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis
Donatella Colaizzo et al.
BLOOD (2007)
Vascular bed-specific thrombosis
W. C. Aird
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings
Donatella Colaizzo et al.
JOURNAL OF MEDICAL GENETICS (2007)
JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses
Christine McMahon et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis
Ozgur Harmanci et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
V. De Stefano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
Linda M. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis
D. Colaizzo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis
S. Regina et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia
Davide Rossi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis
Valerio De Stefano et al.
HEPATOLOGY (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
Massimo Primignani et al.
HEPATOLOGY (2006)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis
Marjorie Boissinot et al.
BLOOD (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
C. E. Eapen et al.
GUT (2006)
Budd-Chiari syndrome: Long-term effect on outcome with transjugular intrahepatic portosystemic shunt
MS Khuroo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
Y Chait et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Risk factors for thrombophilia in extrahepatic portal vein obstruction
M Primignani et al.
HEPATOLOGY (2005)
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
SD Murad et al.
HEPATOLOGY (2004)
Treatment of Budd-Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation
A Attwell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Budd-Chiari syndrome: a review by an expert panel
HLA Janssen et al.
JOURNAL OF HEPATOLOGY (2003)
Extrahepatic portal vein thrombosis: aetiology and determinants of survival
HLA Janssen et al.
GUT (2001)
Cause of portal or hepatic venous thrombosis in adults:: The role of multiple concurrent factors
MH Denninger et al.
HEPATOLOGY (2000)
Share Paper
